PrecisioBiotix Therapeutics
PrivateLast Round
Grant
Jun 16, 2025
Total Funding Raised
$1.48M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PrecisioBiotix Therapeutics is a biotechnology company that develops precision antibacterial biological solutions, including lysin, phage, and amurin products, to combat antibiotic-resistant infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PrecisioBiotix Therapeutics Comparables
Compare PrecisioBiotix Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Locus Biosciences | 82% | |
| Micreos | 82% | |
| BioNTech SE | 78% |
PrecisioBiotix Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2025 |
PrecisioBiotix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 37% MoM.
- Aug 1, 2026
Grew 38% QoQ, from 8 to 11 employees.
Recent news
Latest coverage and updates
- is_developingJul 23, 2026
Precisiobiotix is developing white paper examining the role of lysin-based therapies in India's AMR landscape.
PrecisioBiotix Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PrecisioBiotix Therapeutics's valuation, stock price, and market status.
Is PrecisioBiotix Therapeutics a public or private company?
PrecisioBiotix Therapeutics is a private company.
What is the current stock price of PrecisioBiotix Therapeutics?
PrecisioBiotix Therapeutics is a private company with no public stock price. Caplight tracks PrecisioBiotix Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is PrecisioBiotix Therapeutics worth (valuation)?
Valuation information for PrecisioBiotix Therapeutics is not publicly available.
Can I buy PrecisioBiotix Therapeutics stock?
PrecisioBiotix Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PrecisioBiotix Therapeutics's last funding round?
PrecisioBiotix Therapeutics's most recent funding round was Grant on June 16, 2025.
Who are the main investors in PrecisioBiotix Therapeutics?
Key investors in PrecisioBiotix Therapeutics include Bill & Melinda Gates Foundation.
Will PrecisioBiotix Therapeutics IPO soon?
No public IPO plans have been announced for PrecisioBiotix Therapeutics.
How can I track PrecisioBiotix Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PrecisioBiotix Therapeutics's secondary market activity and sign up for updates.